Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
{{output}}
Background and objectives: Neoadjuvant chemoimmunotherapy (NACI) for node-positive breast cancer may induce immune cell activation in regional lymph nodes (LN), confounding post-NACI imaging. Here we evaluated RECIST 1.1 criteria... ...
